We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601111:SSEAir China Limited Class A Analysis

Data as of 2026-06-09 - not real-time

CN¥6.16

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Air China is trading at ¥6.16, barely above the computed support level of ¥6.14 and well below its 20‑day SMA of ¥6.70, indicating immediate price pressure. Technical indicators are bearish: the 50‑day and 200‑day SMAs sit higher than the current price, the RSI hovers around 30, and the MACD histogram is negative with a bearish signal. Fundamentally, the airline posted 11% revenue growth but margins remain thin (gross ~7%, operating ~3%, profit ~1%) and the company carries an extreme debt‑to‑equity ratio of over 500, limiting financial flexibility. The trailing PE of 56 is nearly double the industry average of 30, and the DCF‑derived fair value of ¥4.59 suggests the stock is currently overvalued. No dividend is paid, removing any income cushion for investors. Volatility over the past 30 days is high at about 32%, though beta is low, implying price swings are driven more by company‑specific factors than market moves. Overall, the combination of bearish technicals, lofty valuation multiples, and a heavy balance‑sheet burden points to a cautious stance in the near term, while modest revenue growth offers a slight upside if the financial structure improves.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price is near technical support and below key moving averages
  • Bearish MACD and low RSI suggest limited upside
  • High valuation relative to DCF and industry peers

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth of 11% provides a modest earnings tailwind
  • Persistent high debt and low profitability constrain upside
  • Valuation remains stretched despite modest earnings improvement

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Long‑term demand for air travel in China could support recovery
  • Heavy leverage and lack of dividend limit total return potential
  • Current price still above DCF fair value, indicating limited upside

Key Metrics & Analysis

Financial Health

Revenue Growth11.30%
Profit Margin1.13%
P/E Ratio56.0
ROE2.03%
ROA0.51%
Debt/Equity532.94
P/B Ratio2.4
Op. Cash FlowCN¥42.9B
Free Cash FlowCN¥13.4B
Industry P/E30.1

Technical Analysis

TrendBearish
RSI30.4
SupportCN¥6.14
ResistanceCN¥7.14
MA 20CN¥6.70
MA 50CN¥6.83
MA 200CN¥7.83
MACDBearish
VolumeStable
Fear & Greed Index87.64

Valuation

Fair ValueCN¥4.59
GradeOvervalued
TypeValue

Risk Assessment

Beta0.18
Volatility32.18%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.